The association of empirical treatment with oseltamivir with the outcome of critically ill patients admitted with severe acute respiratory illness (SARI)
Raymond M Khan, Linah Mosleh AlMarashi, Mohamad-Hani Temsah, Ghassan Ali Ahmed Al Ghamdi, Musharaf Sadat, Felwa Bin Humaid, Jesna Jose, Fahad Al-Hameed, Kasim Al Khatib, Mohammed AlObaidi, Mohammed Shaim Alanezi, Faisal Fouad Al-Basseet, Rasha Alanazi, Yaseen Arabi · 2026
Read The association of empirical treatment with oseltamivir with the outcome of critically ill patients admitted with severe acute respiratory illness (SARI) by Raymond M Khan, Linah Mosleh AlMarashi, Mohamad-Hani Temsah, Ghassan Ali Ahmed Al Ghamdi, Musharaf Sadat, Felwa Bin Humaid, Jesna Jose, Fahad Al-Hameed, Kasim Al Khatib, Mohammed AlObaidi, Mohammed Shaim Alanezi, Faisal Fouad Al-Basseet, Rasha Alanazi, Yaseen Arabi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473781.txt.
Description
ObjectiveNeuraminidase inhibitors (NAIs) are widely used empirically in critically ill patients with suspected influenza; however, their effect on mortality remains uncertain. This multicenter study evaluates the association between empirical treatment with oseltamivir and the outcome of critically ill patients with Severe Acute Respiratory Infection (SARI) admitted to the Intensive Care Unit (ICU).
Catalog record
| CREATOR | Raymond M Khan, Linah Mosleh AlMarashi, Mohamad-Hani Temsah, Ghassan Ali Ahmed Al Ghamdi, Musharaf Sadat, Felwa Bin Humaid, Jesna Jose, Fahad Al-Hameed, Kasim Al Khatib, Mohammed AlObaidi, Mohammed Shaim Alanezi, Faisal Fouad Al-Basseet, Rasha Alanazi, Yaseen Arabi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |